GLP-1 Weight Loss: Realistic Results, Timelines, and What Actually Drives Them
GLP-1 medications produce the largest average weight loss of any FDA-approved pharmacologic option, with clinical trials showing 15 to 22.5% of body weight lost over 68 to 72 weeks. Real-world results vary more than social media suggests, and understanding the actual trajectory (including plateaus and what happens after you stop) helps you set realistic expectations. This guide covers what the data shows, what month-by-month progress typically looks like, and the factors that separate top responders from slow responders.
- Average weight loss: 15% on semaglutide (STEP 1), up to 22.5% on tirzepatide (SURMOUNT-1)
- Results are not linear; fastest loss is usually in months 2 to 4
- A plateau at 6 to 9 months is normal and rarely means the drug has stopped working
- Protein intake and resistance training are the biggest drivers of fat (not muscle) loss
- Stopping treatment leads to regain of about two-thirds of lost weight within a year
What the Clinical Trials Actually Showed
The weight loss numbers quoted for GLP-1 medications come from large, randomized, placebo-controlled trials that followed patients for 68 to 72 weeks. These are the benchmarks to compare your expectations against.
Semaglutide (STEP 1): Adults without diabetes on 2.4 mg weekly lost an average of 14.9% of body weight over 68 weeks versus 2.4% on placebo. For someone starting at 220 pounds, that works out to about 33 pounds.
Tirzepatide (SURMOUNT-1): Adults without diabetes on 15 mg weekly lost an average of 22.5% of body weight over 72 weeks. The 10 mg dose produced 21.4% loss and the 5 mg dose produced 16%.
Head-to-head (SURMOUNT-5): In a direct comparison published in 2025, tirzepatide produced about 47% more weight loss than semaglutide over 72 weeks.
Older GLP-1s: Liraglutide (Saxenda) and dulaglutide (Trulicity) produce more modest results of 5 to 7% average body weight loss, which is why they have largely been replaced by semaglutide and tirzepatide for weight management. Our medications that help you lose 15 to 22% of body weight article covers the full benchmark data, and our breakdown of semaglutide weight loss results shows the distribution, not just averages.
About one in three patients on semaglutide lose 20% or more, while about one in three lose less than 10%. Tirzepatide shifts the curve higher: more than half of patients lose 20% or more on the 15 mg dose.
Month-by-Month Timeline
Results are never linear. Most patients see the fastest loss in the first four months, a slower middle period, and a plateau before either the next dose increase or the natural limit of what their body will lose on that dose.
The first two to four weeks tend to show minimal weight loss because the starting dose is deliberately subtherapeutic (0.25 mg for semaglutide, 2.5 mg for tirzepatide). Patients often feel discouraged during this window. Weight loss typically accelerates once you reach 1 mg semaglutide or 5 mg tirzepatide, which is usually around week 8 to 12. Our piece on how long semaglutide takes to work walks through the expected timeline in more detail.
Why Progress Stalls (and How to Break a Plateau)
Almost every patient hits at least one plateau, and most hit a major one around months 6 to 9. This is rarely a sign that the medication has stopped working. A few patterns are almost always responsible.
Your body has adapted to the current dose. GLP-1s work by suppressing appetite, and that effect partly wanes as your body adjusts. Moving to the next dose often restarts progress. Our guides on Mounjaro weight loss stalls and Wegovy plateaus cover when a dose increase is appropriate.
Calorie intake has drifted up. As nausea fades, patients often add back calories without realizing it. Tracking intake for two weeks usually reveals the issue.
Protein intake is too low. When protein is under-consumed, a larger portion of weight loss comes from muscle rather than fat, which drops your resting metabolic rate and slows progress. Our protein on GLP-1 guide covers target intake, and the GLP-1 muscle loss article explains why this matters beyond aesthetics.
The medication is genuinely not working for you. A small percentage of patients are non-responders. If you have been at the maximum tolerated dose for 3 to 4 months with no progress, it is worth discussing a switch. Our Ozempic not working guide walks through the decision framework.
What Drives Top Responder Results
Patients who lose the most weight on GLP-1 medications tend to share a few specific habits, not genetics or luck.
They prioritize protein. Target is typically 0.7 to 1 gram per pound of goal body weight, which is significantly more than most people eat naturally on reduced appetite. Our high-protein diet on GLP-1 guide covers how to hit the number when you are not hungry.
They maintain resistance training. Strength training 2 to 4 times per week preserves muscle mass during rapid weight loss, which keeps metabolism elevated and produces better body composition. Our GLP-1 exercise guide and body composition data on semaglutide make the case with real numbers.
They stay hydrated and manage electrolytes. Rapid weight loss comes with significant fluid shifts. Our guide to hydration and electrolytes on GLP-1 covers what to replace and how much.
They stick with it. Adherence is the single strongest predictor of long-term results. Patients who miss multiple doses or stop for extended periods lose the momentum the medication creates.
What Happens When You Stop
This is the most important thing to understand before starting. GLP-1 medications are chronic therapies, not short courses.
STEP 4 (semaglutide withdrawal trial): Patients who switched to placebo after 20 weeks regained two-thirds of the weight they had lost within a year.
SURMOUNT-4 (tirzepatide withdrawal trial): Patients who stopped tirzepatide regained about 14% of their body weight within a year, while those who continued lost additional weight.
The regain happens because the underlying biology (appetite, gastric emptying, insulin sensitivity) returns to baseline when the drug is cleared. Your body does not "remember" the lower weight. Our guides on what happens when you stop Ozempic and weight regain after stopping GLP-1s cover the science and what maintenance strategies actually work. For most patients, the right framing is long-term metabolic therapy, similar to how statins or blood pressure medications are used for life.
Frequently Asked Questions
How much weight can I realistically expect to lose?
The honest answer is that averages from trials (15% on semaglutide, 22.5% on tirzepatide at top doses) are good benchmarks, but individual results range from under 5% to over 30%. Starting BMI, dose, adherence, and lifestyle all influence where you land on the curve.
Why am I not losing weight on my GLP-1 medication?
The most common reasons are being on a subtherapeutic dose, unrecognized calorie creep, inadequate protein intake, or genuine non-response. Our guide on Ozempic not working walks through each possibility.
Is weight loss faster on tirzepatide than semaglutide?
On average, yes. The SURMOUNT-5 head-to-head trial showed about 47% more weight loss with tirzepatide over 72 weeks. Individual response varies, and some patients tolerate or respond to semaglutide better.
Will I regain the weight if I stop?
Most patients regain a significant portion, typically two-thirds within a year. This is why GLP-1s are considered long-term therapies rather than short-course interventions.
How do I avoid losing muscle on a GLP-1?
Target 0.7 to 1 gram of protein per pound of goal body weight and do resistance training at least 2 to 3 times per week. Without both, roughly 25 to 40% of weight lost will come from lean mass.
Disclaimer
This content is for informational purposes and does not replace professional medical advice. Consult your physician before starting any medication.